XFOR logo

X4 Pharmaceuticals (XFOR) Cash And Cash Equivalents

Annual Cash & Cash Equivalents

$99.22 M
-$22.50 M-18.49%

December 31, 2023


Summary


Performance

XFOR Cash And Cash Equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherXFORbalance sheetmetrics:

Quarterly Cash And Cash Equivalents

$97.41 M
-$49.81 M-33.83%

September 30, 2024


Summary


Performance

XFOR Quarterly Cash And Cash Equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherXFORbalance sheetmetrics:

Cash And Cash Equivalents Formula

Cash & Cash Equivalents = Cash + Short-Term Investments

XFOR Cash And Cash Equivalents Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-18.5%-33.8%
3 y3 years+26.1%-33.8%
5 y5 years+222.6%+27.8%

XFOR Cash And Cash Equivalents Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-18.5%+21.3%-33.8%+105.6%
5 y5-year-21.4%+26.1%-33.8%+105.6%
alltimeall time-21.4%+3169.1%-33.8%+3109.6%

X4 Pharmaceuticals Cash And Cash Equivalents History

DateAnnualQuarterly
Sep 2024
-
$97.41 M(-33.8%)
Jun 2024
-
$147.22 M(+143.4%)
Mar 2024
-
$60.49 M(-39.0%)
Dec 2023
$99.22 M(-18.5%)
$99.22 M(-24.6%)
Sep 2023
-
$131.58 M(-3.6%)
Jun 2023
-
$136.43 M(+46.1%)
Mar 2023
-
$93.41 M(-23.3%)
Dec 2022
$121.72 M(+48.8%)
$121.72 M(+52.4%)
Sep 2022
-
$79.86 M(+68.5%)
Jun 2022
-
$47.38 M(-28.7%)
Mar 2022
-
$66.43 M(-18.8%)
Dec 2021
$81.79 M(+3.9%)
$81.79 M(+7.1%)
Sep 2021
-
$76.39 M(-19.7%)
Jun 2021
-
$95.16 M(-17.2%)
Mar 2021
-
$114.94 M(+46.0%)
DateAnnualQuarterly
Dec 2020
$78.71 M(-37.6%)
$78.71 M(-11.4%)
Sep 2020
-
$88.81 M(-14.4%)
Jun 2020
-
$103.74 M(-9.8%)
Mar 2020
-
$115.05 M(-8.8%)
Dec 2019
$126.18 M(+310.3%)
$126.18 M(+65.5%)
Sep 2019
-
$76.25 M(-15.4%)
Jun 2019
-
$90.18 M(+304.4%)
Mar 2019
-
$22.30 M(-27.5%)
Dec 2018
$30.75 M(-60.0%)
$30.75 M(-24.5%)
Sep 2018
-
$40.75 M(-18.4%)
Jun 2018
-
$49.94 M(-22.0%)
Mar 2018
-
$64.00 M(-16.7%)
Dec 2017
$76.79 M(+2430.2%)
$76.79 M(+192.5%)
Sep 2017
-
$26.25 M(+765.0%)
Dec 2016
$3.04 M(-55.1%)
$3.04 M
Dec 2015
$6.76 M
-

FAQ

  • What is X4 Pharmaceuticals annual cash & cash equivalents?
  • What is the all time high annual cash & cash equivalents for X4 Pharmaceuticals?
  • What is X4 Pharmaceuticals annual cash & cash equivalents year-on-year change?
  • What is X4 Pharmaceuticals quarterly cash and cash equivalents?
  • What is the all time high quarterly cash and cash equivalents for X4 Pharmaceuticals?
  • What is X4 Pharmaceuticals quarterly cash and cash equivalents year-on-year change?

What is X4 Pharmaceuticals annual cash & cash equivalents?

The current annual cash & cash equivalents of XFOR is $99.22 M

What is the all time high annual cash & cash equivalents for X4 Pharmaceuticals?

X4 Pharmaceuticals all-time high annual cash & cash equivalents is $126.18 M

What is X4 Pharmaceuticals annual cash & cash equivalents year-on-year change?

Over the past year, XFOR annual cash & cash equivalents has changed by -$22.50 M (-18.49%)

What is X4 Pharmaceuticals quarterly cash and cash equivalents?

The current quarterly cash and cash equivalents of XFOR is $97.41 M

What is the all time high quarterly cash and cash equivalents for X4 Pharmaceuticals?

X4 Pharmaceuticals all-time high quarterly cash and cash equivalents is $147.22 M

What is X4 Pharmaceuticals quarterly cash and cash equivalents year-on-year change?

Over the past year, XFOR quarterly cash and cash equivalents has changed by -$49.81 M (-33.83%)